Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

被引：29

作者：

Dummer, R. ^{[1
]}

Hauschild, A. ^{[1
]}

Jost, L. ^{[2
]}

Grp, E. S. M. O. Guidelines Working

机构：

[1] Univ Kiel, Dept Dermatol, D-2300 Kiel, Germany

[2] Kantonsspital, Dept Oncol, Bruderholz, Germany

来源：

ANNALS OF ONCOLOGY | 2008年 / 19卷

关键词：

D O I：

10.1093/annonc/mdn100

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：86 / 88

页数：3

共 14 条

[1]

*AUSTR CANC NETW, 1997, GUID MAN CUT MEL

[2] Detection of melanoma relapse:: First comparative analysis on imaging techniques versus S100 protein [J].

Beyeler, Mirjam ;

Waldispuehl, Severa ;

Strobel, Klaus ;

Joller-Jemelka, Helen I. ;

Burg, Guenter ;

Dummer, Reinhard .

DERMATOLOGY, 2006, 213 (03) :187-191

[3] Micro-melanoma detection:: a clinical study on 206 consecutive cases of pigmented skin lesions with a diameter ≤ 3 mm [J].

Bono, A. ;

Tolomio, E. ;

Trincone, S. ;

Bartoli, C. ;

Tomatis, S. ;

Carbone, A. ;

Santinami, M. .

BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (03) :570-573

[4] Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: Rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia [J].

de Vries, E ;

Bray, FI ;

Coebergh, JWW ;

Parkin, DM .

INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (01) :119-126

[5] Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma [J].

Dummer, R ;

Panizzon, R ;

Bloch, PH ;

Burg, G .

DERMATOLOGY, 2005, 210 (01) :39-44

[6]

Eggermont Alexander M M, 2002, Expert Rev Anticancer Ther, V2, P563, DOI 10.1586/14737140.2.5.563

[7] A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays [J].

Farshad, A ;

Burg, G ;

Panizzon, R ;

Dummer, R .

BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (06) :1042-1046

[8] Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials [J].

Huncharek, M ;

Caubet, JF ;

McGarry, R .

MELANOMA RESEARCH, 2001, 11 (01) :75-81

[9] Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: A randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group [J].

Kaufmann, R ;

Spieth, K ;

Leiter, U ;

Mauch, C ;

von den Driesch, P ;

Vogt, T ;

Linse, R ;

Tilgen, W ;

Schadendorf, D ;

Becker, JC ;

Sebastian, G ;

Krengel, S ;

Kretschmer, L ;

Garbe, C ;

Dummer, R .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) :9001-9007

[10] Final results of the EORTC 18871/DKG 80-1 randomised phase III trial:: rIFN-α2b versus rIFN-γ versus ISCADOR M® versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis [J].

Kleeberg, UR ;

Suciu, S ;

Bröcker, EB ;

Ruiter, DJ ;

Chartier, C ;

Liénard, D ;

Marsden, J ;

Schadendorf, D ;

Eggermont, AMM .

EUROPEAN JOURNAL OF CANCER, 2004, 40 (03) :390-402

← 1 2 →